BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26300629)

  • 1. Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study.
    Niu NK; Yin JJ; Yang YX; Wang ZL; Zhou ZW; He ZX; Chen XW; Zhang X; Duan W; Yang T; Zhou SF
    Drug Des Devel Ther; 2015; 9():4441-70. PubMed ID: 26300629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation, characterization, and in-vitro cytotoxicity of nanoliposomes loaded with anti-tubercular drugs and TGF-β1 siRNA for improving spinal tuberculosis therapy.
    Yang Z; Lou C; Wang X; Wang C; Shi Z; Niu N
    BMC Infect Dis; 2022 Nov; 22(1):824. PubMed ID: 36348467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells.
    Chen CW; Lu DW; Yeh MK; Shiau CY; Chiang CH
    Int J Nanomedicine; 2011; 6():2567-80. PubMed ID: 22128247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance.
    Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Huang K; Chen X; Zhang Z; He Q
    Int J Pharm; 2014 Dec; 477(1-2):590-600. PubMed ID: 25448564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing miR-125b-5p attenuates inflammatory response and apoptosis inhibition in mycobacterium tuberculosis-infected human macrophages by targeting DNA damage-regulated autophagy modulator 2 (DRAM2).
    Liu G; Wan Q; Li J; Hu X; Gu X; Xu S
    Cell Cycle; 2020 Nov; 19(22):3182-3194. PubMed ID: 33121314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylated hyaluronic acid-modified liposomal delivery system with anti-γ-glutamylcyclotransferase siRNA for drug-resistant MCF-7 breast cancer therapy.
    Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Fu H; Zhang Z; He Q
    J Pharm Sci; 2015 Feb; 104(2):476-84. PubMed ID: 25256603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
    Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
    Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A lipid nanoparticle system improves siRNA efficacy in RPE cells and a laser-induced murine CNV model.
    Liu HA; Liu YL; Ma ZZ; Wang JC; Zhang Q
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(7):4789-94. PubMed ID: 21519028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soybean lectin induces autophagy through P2RX7 dependent activation of NF-κB-ROS pathway to kill intracellular mycobacteria.
    Mishra A; Behura A; Kumar A; Ghosh A; Naik L; Mawatwal S; Mohanty SS; Mishra A; Saha S; Bhutia SK; Singh R; Dhiman R
    Biochim Biophys Acta Gen Subj; 2021 Feb; 1865(2):129806. PubMed ID: 33253803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutral PEGylated liposomal formulation for efficient folate-mediated delivery of MCL1 siRNA to activated macrophages.
    Nogueira E; Freitas J; Loureiro A; Nogueira P; Gomes AC; Preto A; Carmo AM; Moreira A; Cavaco-Paulo A
    Colloids Surf B Biointerfaces; 2017 Jul; 155():459-465. PubMed ID: 28472749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-Delivery Of Dihydroartemisinin And HMGB1 siRNA By TAT-Modified Cationic Liposomes Through The TLR4 Signaling Pathway For Treatment Of Lupus Nephritis.
    Diao L; Tao J; Wang Y; Hu Y; He W
    Int J Nanomedicine; 2019; 14():8627-8645. PubMed ID: 31806961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance.
    Haghiralsadat F; Amoabediny G; Naderinezhad S; Zandieh-Doulabi B; Forouzanfar T; Helder MN
    Int J Nanomedicine; 2018; 13():3853-3866. PubMed ID: 30013340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of PI3K/Akt/mTOR pathway-mediated macrophage autophagy in affecting the phenotype transformation of lung fibroblasts induced by silica dust exposure.
    DU Y; Huang F; Guan L; Zeng M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 48(8):1152-1162. PubMed ID: 37875355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of smad2 and Erk/Akt cascade in TGF-β1-induced apoptosis in human gingival epithelial cells.
    Yoshimoto T; Fujita T; Kajiya M; Matsuda S; Ouhara K; Shiba H; Kurihara H
    Cytokine; 2015 Sep; 75(1):165-73. PubMed ID: 25882870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvesicle-mediated delivery of transforming growth factor β1 siRNA for the suppression of tumor growth in mice.
    Zhang Y; Li L; Yu J; Zhu D; Zhang Y; Li X; Gu H; Zhang CY; Zen K
    Biomaterials; 2014 May; 35(14):4390-400. PubMed ID: 24565517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Transforming Growth Factor-Beta1 (TGF-β1) Inhibits Tumorigenesis of Anaplastic Thyroid Carcinoma Cells Through ERK1/2-NFκkB-PUMA Signaling.
    Yin Q; Liu S; Dong A; Mi X; Hao F; Zhang K
    Med Sci Monit; 2016 Jun; 22():2267-77. PubMed ID: 27356491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Gold Nanoparticle Platform for the Delivery of Functional TGF-β1 siRNA Into Cancer Cells.
    Wu J; Liu B; Wu H; Wu Y; Zhang W; Zhao S; Zhang L; Pan X; Gao W; Wang X; Yuan Y; Zhang Y
    J Biomed Nanotechnol; 2016 Apr; 12(4):800-10. PubMed ID: 27301206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages.
    Lee HJ; Ko HJ; Kim SH; Jung YJ
    PLoS One; 2019; 14(3):e0199799. PubMed ID: 30865638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.